June 30, 2020
The Ministry of Health, Labor and Welfare (MHLW) approved a throng of new medicines and indications on June 29, with Novartis nabbing the simultaneous okay for five products including Entresto (sacubitril valsartan sodium hydrate), which carries no subtype restriction for...read more